nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—ABCB1—ulcerative colitis	0.231	1	CbGaD
Sirolimus—SLCO1B1—Sulfasalazine—ulcerative colitis	0.0585	0.143	CbGbCtD
Sirolimus—CYP3A4—Budesonide—ulcerative colitis	0.0297	0.0726	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Hydrocortisone—ulcerative colitis	0.0276	0.0674	CbGbCtD
Sirolimus—CYP3A7—Hydrocortisone—ulcerative colitis	0.0276	0.0674	CbGbCtD
Sirolimus—CYP3A5—Sulfasalazine—ulcerative colitis	0.0258	0.063	CbGbCtD
Sirolimus—ABCB1—Methylprednisolone—ulcerative colitis	0.0221	0.0541	CbGbCtD
Sirolimus—CYP3A5—Hydrocortisone—ulcerative colitis	0.0207	0.0506	CbGbCtD
Sirolimus—CYP3A7—Dexamethasone—ulcerative colitis	0.0171	0.0419	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Dexamethasone—ulcerative colitis	0.0171	0.0419	CbGbCtD
Sirolimus—ABCB1—Betamethasone—ulcerative colitis	0.0144	0.0352	CbGbCtD
Sirolimus—ABCB1—Prednisolone—ulcerative colitis	0.0142	0.0347	CbGbCtD
Sirolimus—ABCB1—Hydrocortisone—ulcerative colitis	0.0135	0.0329	CbGbCtD
Sirolimus—ABCB1—Prednisone—ulcerative colitis	0.0134	0.0328	CbGbCtD
Sirolimus—CYP3A4—Methylprednisolone—ulcerative colitis	0.0133	0.0324	CbGbCtD
Sirolimus—CYP3A4—Nicotine—ulcerative colitis	0.0129	0.0316	CbGbCtD
Sirolimus—CYP3A5—Dexamethasone—ulcerative colitis	0.0129	0.0314	CbGbCtD
Sirolimus—CYP3A4—Cholecalciferol—ulcerative colitis	0.0116	0.0283	CbGbCtD
Sirolimus—CYP3A4—Triamcinolone—ulcerative colitis	0.01	0.0246	CbGbCtD
Sirolimus—CYP3A4—Betamethasone—ulcerative colitis	0.00862	0.0211	CbGbCtD
Sirolimus—CYP3A4—Prednisolone—ulcerative colitis	0.00851	0.0208	CbGbCtD
Sirolimus—ABCB1—Dexamethasone—ulcerative colitis	0.00837	0.0205	CbGbCtD
Sirolimus—CYP3A4—Hydrocortisone—ulcerative colitis	0.00806	0.0197	CbGbCtD
Sirolimus—CYP3A4—Prednisone—ulcerative colitis	0.00803	0.0196	CbGbCtD
Sirolimus—CYP3A4—Dexamethasone—ulcerative colitis	0.00501	0.0123	CbGbCtD
Sirolimus—EIF4E—lymphoid tissue—ulcerative colitis	0.00325	0.103	CbGeAlD
Sirolimus—EIF4E—digestive system—ulcerative colitis	0.00321	0.101	CbGeAlD
Sirolimus—FGF2—smooth muscle tissue—ulcerative colitis	0.00248	0.0782	CbGeAlD
Sirolimus—EIF4E—liver—ulcerative colitis	0.00239	0.0754	CbGeAlD
Sirolimus—MTOR—epithelium—ulcerative colitis	0.00163	0.0515	CbGeAlD
Sirolimus—MTOR—smooth muscle tissue—ulcerative colitis	0.00157	0.0496	CbGeAlD
Sirolimus—FKBP1A—epithelium—ulcerative colitis	0.00147	0.0463	CbGeAlD
Sirolimus—FKBP1A—smooth muscle tissue—ulcerative colitis	0.00142	0.0446	CbGeAlD
Sirolimus—MTOR—lymphoid tissue—ulcerative colitis	0.00126	0.0397	CbGeAlD
Sirolimus—MTOR—digestive system—ulcerative colitis	0.00124	0.0392	CbGeAlD
Sirolimus—FKBP1A—lymphoid tissue—ulcerative colitis	0.00113	0.0357	CbGeAlD
Sirolimus—FKBP1A—digestive system—ulcerative colitis	0.00112	0.0352	CbGeAlD
Sirolimus—CYP3A7—liver—ulcerative colitis	0.00103	0.0325	CbGeAlD
Sirolimus—SLC47A1—digestive system—ulcerative colitis	0.000961	0.0303	CbGeAlD
Sirolimus—SLCO1B1—digestive system—ulcerative colitis	0.000949	0.0299	CbGeAlD
Sirolimus—MTOR—liver—ulcerative colitis	0.000926	0.0292	CbGeAlD
Sirolimus—CYP3A7-CYP3A51P—liver—ulcerative colitis	0.000876	0.0276	CbGeAlD
Sirolimus—FKBP1A—liver—ulcerative colitis	0.000833	0.0263	CbGeAlD
Sirolimus—SLC47A1—liver—ulcerative colitis	0.000716	0.0226	CbGeAlD
Sirolimus—SLCO1B1—liver—ulcerative colitis	0.000707	0.0223	CbGeAlD
Sirolimus—Temsirolimus—ABCB1—ulcerative colitis	0.000615	0.357	CrCbGaD
Sirolimus—Tacrolimus—ALB—ulcerative colitis	0.000567	0.329	CrCbGaD
Sirolimus—Tacrolimus—ABCB1—ulcerative colitis	0.000541	0.314	CrCbGaD
Sirolimus—CYP3A5—digestive system—ulcerative colitis	0.000487	0.0153	CbGeAlD
Sirolimus—CYP3A4—digestive system—ulcerative colitis	0.000365	0.0115	CbGeAlD
Sirolimus—CYP3A5—liver—ulcerative colitis	0.000363	0.0114	CbGeAlD
Sirolimus—ABCB1—epithelium—ulcerative colitis	0.00034	0.0107	CbGeAlD
Sirolimus—CYP3A4—liver—ulcerative colitis	0.000272	0.00858	CbGeAlD
Sirolimus—ABCB1—lymphoid tissue—ulcerative colitis	0.000262	0.00825	CbGeAlD
Sirolimus—ABCB1—digestive system—ulcerative colitis	0.000259	0.00815	CbGeAlD
Sirolimus—ABCB1—liver—ulcerative colitis	0.000193	0.00607	CbGeAlD
Sirolimus—Syncope—Triamcinolone—ulcerative colitis	8.09e-05	0.000379	CcSEcCtD
Sirolimus—Syncope—Methylprednisolone—ulcerative colitis	8.07e-05	0.000378	CcSEcCtD
Sirolimus—Discomfort—Hydrocortisone—ulcerative colitis	8.06e-05	0.000378	CcSEcCtD
Sirolimus—Connective tissue disorder—Prednisone—ulcerative colitis	8.05e-05	0.000377	CcSEcCtD
Sirolimus—Nausea—Budesonide—ulcerative colitis	8.03e-05	0.000377	CcSEcCtD
Sirolimus—Oedema—Prednisolone—ulcerative colitis	8.01e-05	0.000375	CcSEcCtD
Sirolimus—Anaphylactic shock—Prednisolone—ulcerative colitis	8.01e-05	0.000375	CcSEcCtD
Sirolimus—Dizziness—Azathioprine—ulcerative colitis	7.98e-05	0.000374	CcSEcCtD
Sirolimus—Loss of consciousness—Triamcinolone—ulcerative colitis	7.93e-05	0.000372	CcSEcCtD
Sirolimus—Loss of consciousness—Methylprednisolone—ulcerative colitis	7.91e-05	0.000371	CcSEcCtD
Sirolimus—Asthenia—Mesalazine—ulcerative colitis	7.89e-05	0.00037	CcSEcCtD
Sirolimus—Shock—Prednisolone—ulcerative colitis	7.88e-05	0.000369	CcSEcCtD
Sirolimus—Cough—Triamcinolone—ulcerative colitis	7.87e-05	0.000369	CcSEcCtD
Sirolimus—Oedema—Hydrocortisone—ulcerative colitis	7.82e-05	0.000367	CcSEcCtD
Sirolimus—Anaphylactic shock—Hydrocortisone—ulcerative colitis	7.82e-05	0.000367	CcSEcCtD
Sirolimus—Tachycardia—Prednisolone—ulcerative colitis	7.81e-05	0.000366	CcSEcCtD
Sirolimus—Hypertension—Triamcinolone—ulcerative colitis	7.79e-05	0.000365	CcSEcCtD
Sirolimus—Pruritus—Mesalazine—ulcerative colitis	7.78e-05	0.000365	CcSEcCtD
Sirolimus—Hypertension—Methylprednisolone—ulcerative colitis	7.77e-05	0.000364	CcSEcCtD
Sirolimus—Infection—Hydrocortisone—ulcerative colitis	7.77e-05	0.000364	CcSEcCtD
Sirolimus—Hyperhidrosis—Prednisolone—ulcerative colitis	7.74e-05	0.000363	CcSEcCtD
Sirolimus—Shock—Hydrocortisone—ulcerative colitis	7.69e-05	0.000361	CcSEcCtD
Sirolimus—Myalgia—Triamcinolone—ulcerative colitis	7.68e-05	0.00036	CcSEcCtD
Sirolimus—Vomiting—Azathioprine—ulcerative colitis	7.68e-05	0.00036	CcSEcCtD
Sirolimus—Nervous system disorder—Hydrocortisone—ulcerative colitis	7.67e-05	0.00036	CcSEcCtD
Sirolimus—Arthralgia—Methylprednisolone—ulcerative colitis	7.66e-05	0.000359	CcSEcCtD
Sirolimus—Myalgia—Methylprednisolone—ulcerative colitis	7.66e-05	0.000359	CcSEcCtD
Sirolimus—Anxiety—Methylprednisolone—ulcerative colitis	7.64e-05	0.000358	CcSEcCtD
Sirolimus—Tachycardia—Hydrocortisone—ulcerative colitis	7.63e-05	0.000358	CcSEcCtD
Sirolimus—Rash—Azathioprine—ulcerative colitis	7.61e-05	0.000357	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	7.61e-05	0.000357	CcSEcCtD
Sirolimus—Dermatitis—Azathioprine—ulcerative colitis	7.6e-05	0.000357	CcSEcCtD
Sirolimus—Skin disorder—Hydrocortisone—ulcerative colitis	7.6e-05	0.000356	CcSEcCtD
Sirolimus—Ill-defined disorder—Betamethasone—ulcerative colitis	7.59e-05	0.000356	CcSEcCtD
Sirolimus—Ill-defined disorder—Dexamethasone—ulcerative colitis	7.59e-05	0.000356	CcSEcCtD
Sirolimus—Discomfort—Triamcinolone—ulcerative colitis	7.59e-05	0.000356	CcSEcCtD
Sirolimus—Discomfort—Methylprednisolone—ulcerative colitis	7.57e-05	0.000355	CcSEcCtD
Sirolimus—Headache—Azathioprine—ulcerative colitis	7.56e-05	0.000355	CcSEcCtD
Sirolimus—Hyperhidrosis—Hydrocortisone—ulcerative colitis	7.56e-05	0.000354	CcSEcCtD
Sirolimus—Diarrhoea—Mesalazine—ulcerative colitis	7.52e-05	0.000353	CcSEcCtD
Sirolimus—Angioedema—Betamethasone—ulcerative colitis	7.48e-05	0.000351	CcSEcCtD
Sirolimus—Angioedema—Dexamethasone—ulcerative colitis	7.48e-05	0.000351	CcSEcCtD
Sirolimus—Anorexia—Hydrocortisone—ulcerative colitis	7.45e-05	0.000349	CcSEcCtD
Sirolimus—Angiopathy—Prednisone—ulcerative colitis	7.43e-05	0.000348	CcSEcCtD
Sirolimus—Confusional state—Methylprednisolone—ulcerative colitis	7.41e-05	0.000347	CcSEcCtD
Sirolimus—Immune system disorder—Prednisone—ulcerative colitis	7.4e-05	0.000347	CcSEcCtD
Sirolimus—Malaise—Dexamethasone—ulcerative colitis	7.38e-05	0.000346	CcSEcCtD
Sirolimus—Malaise—Betamethasone—ulcerative colitis	7.38e-05	0.000346	CcSEcCtD
Sirolimus—Oedema—Triamcinolone—ulcerative colitis	7.36e-05	0.000345	CcSEcCtD
Sirolimus—Anaphylactic shock—Triamcinolone—ulcerative colitis	7.36e-05	0.000345	CcSEcCtD
Sirolimus—Anaphylactic shock—Methylprednisolone—ulcerative colitis	7.35e-05	0.000344	CcSEcCtD
Sirolimus—Syncope—Dexamethasone—ulcerative colitis	7.34e-05	0.000344	CcSEcCtD
Sirolimus—Syncope—Betamethasone—ulcerative colitis	7.34e-05	0.000344	CcSEcCtD
Sirolimus—Infection—Triamcinolone—ulcerative colitis	7.31e-05	0.000343	CcSEcCtD
Sirolimus—Hypotension—Hydrocortisone—ulcerative colitis	7.31e-05	0.000343	CcSEcCtD
Sirolimus—Infection—Methylprednisolone—ulcerative colitis	7.3e-05	0.000342	CcSEcCtD
Sirolimus—Dizziness—Mesalazine—ulcerative colitis	7.27e-05	0.000341	CcSEcCtD
Sirolimus—Shock—Triamcinolone—ulcerative colitis	7.24e-05	0.00034	CcSEcCtD
Sirolimus—Insomnia—Prednisolone—ulcerative colitis	7.24e-05	0.00034	CcSEcCtD
Sirolimus—Shock—Methylprednisolone—ulcerative colitis	7.23e-05	0.000339	CcSEcCtD
Sirolimus—Nervous system disorder—Methylprednisolone—ulcerative colitis	7.2e-05	0.000338	CcSEcCtD
Sirolimus—Loss of consciousness—Betamethasone—ulcerative colitis	7.19e-05	0.000337	CcSEcCtD
Sirolimus—Loss of consciousness—Dexamethasone—ulcerative colitis	7.19e-05	0.000337	CcSEcCtD
Sirolimus—Paraesthesia—Prednisolone—ulcerative colitis	7.19e-05	0.000337	CcSEcCtD
Sirolimus—Tachycardia—Triamcinolone—ulcerative colitis	7.19e-05	0.000337	CcSEcCtD
Sirolimus—Nausea—Azathioprine—ulcerative colitis	7.17e-05	0.000336	CcSEcCtD
Sirolimus—Tachycardia—Methylprednisolone—ulcerative colitis	7.17e-05	0.000336	CcSEcCtD
Sirolimus—Skin disorder—Methylprednisolone—ulcerative colitis	7.14e-05	0.000335	CcSEcCtD
Sirolimus—Malnutrition—Prednisone—ulcerative colitis	7.13e-05	0.000334	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	7.12e-05	0.000334	CcSEcCtD
Sirolimus—Hyperhidrosis—Triamcinolone—ulcerative colitis	7.12e-05	0.000334	CcSEcCtD
Sirolimus—Hyperhidrosis—Methylprednisolone—ulcerative colitis	7.1e-05	0.000333	CcSEcCtD
Sirolimus—Insomnia—Hydrocortisone—ulcerative colitis	7.07e-05	0.000332	CcSEcCtD
Sirolimus—Hypertension—Betamethasone—ulcerative colitis	7.07e-05	0.000331	CcSEcCtD
Sirolimus—Hypertension—Dexamethasone—ulcerative colitis	7.07e-05	0.000331	CcSEcCtD
Sirolimus—Paraesthesia—Hydrocortisone—ulcerative colitis	7.02e-05	0.000329	CcSEcCtD
Sirolimus—Vomiting—Mesalazine—ulcerative colitis	6.99e-05	0.000328	CcSEcCtD
Sirolimus—Myalgia—Dexamethasone—ulcerative colitis	6.97e-05	0.000327	CcSEcCtD
Sirolimus—Myalgia—Betamethasone—ulcerative colitis	6.97e-05	0.000327	CcSEcCtD
Sirolimus—Anxiety—Dexamethasone—ulcerative colitis	6.94e-05	0.000326	CcSEcCtD
Sirolimus—Anxiety—Betamethasone—ulcerative colitis	6.94e-05	0.000326	CcSEcCtD
Sirolimus—Rash—Mesalazine—ulcerative colitis	6.93e-05	0.000325	CcSEcCtD
Sirolimus—Dermatitis—Mesalazine—ulcerative colitis	6.93e-05	0.000325	CcSEcCtD
Sirolimus—Headache—Mesalazine—ulcerative colitis	6.89e-05	0.000323	CcSEcCtD
Sirolimus—Discomfort—Dexamethasone—ulcerative colitis	6.89e-05	0.000323	CcSEcCtD
Sirolimus—Discomfort—Betamethasone—ulcerative colitis	6.89e-05	0.000323	CcSEcCtD
Sirolimus—Dyspepsia—Hydrocortisone—ulcerative colitis	6.88e-05	0.000323	CcSEcCtD
Sirolimus—Hypotension—Methylprednisolone—ulcerative colitis	6.86e-05	0.000322	CcSEcCtD
Sirolimus—Pain—Prednisolone—ulcerative colitis	6.85e-05	0.000321	CcSEcCtD
Sirolimus—Decreased appetite—Hydrocortisone—ulcerative colitis	6.8e-05	0.000319	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	6.75e-05	0.000317	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	6.71e-05	0.000315	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	6.69e-05	0.000314	CcSEcCtD
Sirolimus—Pain—Hydrocortisone—ulcerative colitis	6.69e-05	0.000314	CcSEcCtD
Sirolimus—Oedema—Betamethasone—ulcerative colitis	6.68e-05	0.000313	CcSEcCtD
Sirolimus—Oedema—Dexamethasone—ulcerative colitis	6.68e-05	0.000313	CcSEcCtD
Sirolimus—Anaphylactic shock—Betamethasone—ulcerative colitis	6.68e-05	0.000313	CcSEcCtD
Sirolimus—Anaphylactic shock—Dexamethasone—ulcerative colitis	6.68e-05	0.000313	CcSEcCtD
Sirolimus—Insomnia—Triamcinolone—ulcerative colitis	6.66e-05	0.000312	CcSEcCtD
Sirolimus—Insomnia—Methylprednisolone—ulcerative colitis	6.64e-05	0.000312	CcSEcCtD
Sirolimus—Infection—Betamethasone—ulcerative colitis	6.64e-05	0.000311	CcSEcCtD
Sirolimus—Infection—Dexamethasone—ulcerative colitis	6.64e-05	0.000311	CcSEcCtD
Sirolimus—Ill-defined disorder—Prednisone—ulcerative colitis	6.61e-05	0.00031	CcSEcCtD
Sirolimus—Paraesthesia—Triamcinolone—ulcerative colitis	6.61e-05	0.00031	CcSEcCtD
Sirolimus—Feeling abnormal—Prednisolone—ulcerative colitis	6.6e-05	0.000309	CcSEcCtD
Sirolimus—Paraesthesia—Methylprednisolone—ulcerative colitis	6.6e-05	0.000309	CcSEcCtD
Sirolimus—Anaemia—Prednisone—ulcerative colitis	6.59e-05	0.000309	CcSEcCtD
Sirolimus—Shock—Betamethasone—ulcerative colitis	6.57e-05	0.000308	CcSEcCtD
Sirolimus—Shock—Dexamethasone—ulcerative colitis	6.57e-05	0.000308	CcSEcCtD
Sirolimus—Dyspnoea—Triamcinolone—ulcerative colitis	6.56e-05	0.000308	CcSEcCtD
Sirolimus—Nervous system disorder—Dexamethasone—ulcerative colitis	6.55e-05	0.000307	CcSEcCtD
Sirolimus—Nervous system disorder—Betamethasone—ulcerative colitis	6.55e-05	0.000307	CcSEcCtD
Sirolimus—Agitation—Prednisone—ulcerative colitis	6.55e-05	0.000307	CcSEcCtD
Sirolimus—Thrombocytopenia—Dexamethasone—ulcerative colitis	6.54e-05	0.000307	CcSEcCtD
Sirolimus—Thrombocytopenia—Betamethasone—ulcerative colitis	6.54e-05	0.000307	CcSEcCtD
Sirolimus—Nausea—Mesalazine—ulcerative colitis	6.53e-05	0.000306	CcSEcCtD
Sirolimus—Tachycardia—Dexamethasone—ulcerative colitis	6.52e-05	0.000306	CcSEcCtD
Sirolimus—Tachycardia—Betamethasone—ulcerative colitis	6.52e-05	0.000306	CcSEcCtD
Sirolimus—Angioedema—Prednisone—ulcerative colitis	6.51e-05	0.000305	CcSEcCtD
Sirolimus—Dyspepsia—Triamcinolone—ulcerative colitis	6.48e-05	0.000304	CcSEcCtD
Sirolimus—Dyspepsia—Methylprednisolone—ulcerative colitis	6.47e-05	0.000303	CcSEcCtD
Sirolimus—Hyperhidrosis—Dexamethasone—ulcerative colitis	6.46e-05	0.000303	CcSEcCtD
Sirolimus—Hyperhidrosis—Betamethasone—ulcerative colitis	6.46e-05	0.000303	CcSEcCtD
Sirolimus—Feeling abnormal—Hydrocortisone—ulcerative colitis	6.44e-05	0.000302	CcSEcCtD
Sirolimus—Malaise—Prednisone—ulcerative colitis	6.43e-05	0.000301	CcSEcCtD
Sirolimus—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	6.39e-05	0.0003	CcSEcCtD
Sirolimus—Syncope—Prednisone—ulcerative colitis	6.39e-05	0.0003	CcSEcCtD
Sirolimus—Anorexia—Betamethasone—ulcerative colitis	6.37e-05	0.000299	CcSEcCtD
Sirolimus—Anorexia—Dexamethasone—ulcerative colitis	6.37e-05	0.000299	CcSEcCtD
Sirolimus—Pain—Triamcinolone—ulcerative colitis	6.3e-05	0.000295	CcSEcCtD
Sirolimus—Loss of consciousness—Prednisone—ulcerative colitis	6.27e-05	0.000294	CcSEcCtD
Sirolimus—Hypotension—Dexamethasone—ulcerative colitis	6.24e-05	0.000293	CcSEcCtD
Sirolimus—Hypotension—Betamethasone—ulcerative colitis	6.24e-05	0.000293	CcSEcCtD
Sirolimus—Abdominal pain—Hydrocortisone—ulcerative colitis	6.18e-05	0.00029	CcSEcCtD
Sirolimus—Body temperature increased—Hydrocortisone—ulcerative colitis	6.18e-05	0.00029	CcSEcCtD
Sirolimus—Hypertension—Prednisone—ulcerative colitis	6.15e-05	0.000289	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	6.09e-05	0.000285	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	6.09e-05	0.000285	CcSEcCtD
Sirolimus—Arthralgia—Prednisone—ulcerative colitis	6.07e-05	0.000285	CcSEcCtD
Sirolimus—Myalgia—Prednisone—ulcerative colitis	6.07e-05	0.000285	CcSEcCtD
Sirolimus—Feeling abnormal—Triamcinolone—ulcerative colitis	6.07e-05	0.000284	CcSEcCtD
Sirolimus—Feeling abnormal—Methylprednisolone—ulcerative colitis	6.05e-05	0.000284	CcSEcCtD
Sirolimus—Anxiety—Prednisone—ulcerative colitis	6.05e-05	0.000284	CcSEcCtD
Sirolimus—Insomnia—Dexamethasone—ulcerative colitis	6.04e-05	0.000283	CcSEcCtD
Sirolimus—Insomnia—Betamethasone—ulcerative colitis	6.04e-05	0.000283	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	6.03e-05	0.000283	CcSEcCtD
Sirolimus—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	6.01e-05	0.000282	CcSEcCtD
Sirolimus—Paraesthesia—Betamethasone—ulcerative colitis	6e-05	0.000281	CcSEcCtD
Sirolimus—Paraesthesia—Dexamethasone—ulcerative colitis	6e-05	0.000281	CcSEcCtD
Sirolimus—Discomfort—Prednisone—ulcerative colitis	6e-05	0.000281	CcSEcCtD
Sirolimus—Hypersensitivity—Prednisolone—ulcerative colitis	5.9e-05	0.000277	CcSEcCtD
Sirolimus—Dyspepsia—Betamethasone—ulcerative colitis	5.88e-05	0.000276	CcSEcCtD
Sirolimus—Dyspepsia—Dexamethasone—ulcerative colitis	5.88e-05	0.000276	CcSEcCtD
Sirolimus—Body temperature increased—Triamcinolone—ulcerative colitis	5.82e-05	0.000273	CcSEcCtD
Sirolimus—Oedema—Prednisone—ulcerative colitis	5.82e-05	0.000273	CcSEcCtD
Sirolimus—Anaphylactic shock—Prednisone—ulcerative colitis	5.82e-05	0.000273	CcSEcCtD
Sirolimus—Abdominal pain—Methylprednisolone—ulcerative colitis	5.81e-05	0.000272	CcSEcCtD
Sirolimus—Decreased appetite—Dexamethasone—ulcerative colitis	5.81e-05	0.000272	CcSEcCtD
Sirolimus—Decreased appetite—Betamethasone—ulcerative colitis	5.81e-05	0.000272	CcSEcCtD
Sirolimus—Infection—Prednisone—ulcerative colitis	5.78e-05	0.000271	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	5.77e-05	0.00027	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Betamethasone—ulcerative colitis	5.77e-05	0.00027	CcSEcCtD
Sirolimus—Hypersensitivity—Hydrocortisone—ulcerative colitis	5.76e-05	0.00027	CcSEcCtD
Sirolimus—Shock—Prednisone—ulcerative colitis	5.72e-05	0.000268	CcSEcCtD
Sirolimus—Pain—Dexamethasone—ulcerative colitis	5.71e-05	0.000268	CcSEcCtD
Sirolimus—Pain—Betamethasone—ulcerative colitis	5.71e-05	0.000268	CcSEcCtD
Sirolimus—Nervous system disorder—Prednisone—ulcerative colitis	5.71e-05	0.000268	CcSEcCtD
Sirolimus—Tachycardia—Prednisone—ulcerative colitis	5.68e-05	0.000266	CcSEcCtD
Sirolimus—Skin disorder—Prednisone—ulcerative colitis	5.65e-05	0.000265	CcSEcCtD
Sirolimus—Hyperhidrosis—Prednisone—ulcerative colitis	5.62e-05	0.000264	CcSEcCtD
Sirolimus—Asthenia—Hydrocortisone—ulcerative colitis	5.61e-05	0.000263	CcSEcCtD
Sirolimus—Anorexia—Prednisone—ulcerative colitis	5.55e-05	0.00026	CcSEcCtD
Sirolimus—Pruritus—Hydrocortisone—ulcerative colitis	5.53e-05	0.000259	CcSEcCtD
Sirolimus—Feeling abnormal—Dexamethasone—ulcerative colitis	5.51e-05	0.000258	CcSEcCtD
Sirolimus—Feeling abnormal—Betamethasone—ulcerative colitis	5.51e-05	0.000258	CcSEcCtD
Sirolimus—Gastrointestinal pain—Betamethasone—ulcerative colitis	5.46e-05	0.000256	CcSEcCtD
Sirolimus—Gastrointestinal pain—Dexamethasone—ulcerative colitis	5.46e-05	0.000256	CcSEcCtD
Sirolimus—Hypersensitivity—Triamcinolone—ulcerative colitis	5.42e-05	0.000254	CcSEcCtD
Sirolimus—Hypersensitivity—Methylprednisolone—ulcerative colitis	5.41e-05	0.000254	CcSEcCtD
Sirolimus—Diarrhoea—Hydrocortisone—ulcerative colitis	5.35e-05	0.000251	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Prednisone—ulcerative colitis	5.3e-05	0.000249	CcSEcCtD
Sirolimus—Dizziness—Prednisolone—ulcerative colitis	5.29e-05	0.000248	CcSEcCtD
Sirolimus—Asthenia—Triamcinolone—ulcerative colitis	5.28e-05	0.000248	CcSEcCtD
Sirolimus—Body temperature increased—Dexamethasone—ulcerative colitis	5.28e-05	0.000248	CcSEcCtD
Sirolimus—Abdominal pain—Betamethasone—ulcerative colitis	5.28e-05	0.000248	CcSEcCtD
Sirolimus—Abdominal pain—Dexamethasone—ulcerative colitis	5.28e-05	0.000248	CcSEcCtD
Sirolimus—Body temperature increased—Betamethasone—ulcerative colitis	5.28e-05	0.000248	CcSEcCtD
Sirolimus—Asthenia—Methylprednisolone—ulcerative colitis	5.27e-05	0.000247	CcSEcCtD
Sirolimus—Insomnia—Prednisone—ulcerative colitis	5.26e-05	0.000247	CcSEcCtD
Sirolimus—Paraesthesia—Prednisone—ulcerative colitis	5.22e-05	0.000245	CcSEcCtD
Sirolimus—Pruritus—Triamcinolone—ulcerative colitis	5.21e-05	0.000244	CcSEcCtD
Sirolimus—Pruritus—Methylprednisolone—ulcerative colitis	5.2e-05	0.000244	CcSEcCtD
Sirolimus—Dizziness—Hydrocortisone—ulcerative colitis	5.17e-05	0.000242	CcSEcCtD
Sirolimus—Dyspepsia—Prednisone—ulcerative colitis	5.12e-05	0.00024	CcSEcCtD
Sirolimus—Decreased appetite—Prednisone—ulcerative colitis	5.06e-05	0.000237	CcSEcCtD
Sirolimus—Rash—Prednisolone—ulcerative colitis	5.05e-05	0.000237	CcSEcCtD
Sirolimus—Dermatitis—Prednisolone—ulcerative colitis	5.04e-05	0.000236	CcSEcCtD
Sirolimus—Diarrhoea—Methylprednisolone—ulcerative colitis	5.03e-05	0.000236	CcSEcCtD
Sirolimus—Headache—Prednisolone—ulcerative colitis	5.02e-05	0.000235	CcSEcCtD
Sirolimus—Constipation—Prednisone—ulcerative colitis	4.98e-05	0.000233	CcSEcCtD
Sirolimus—Vomiting—Hydrocortisone—ulcerative colitis	4.97e-05	0.000233	CcSEcCtD
Sirolimus—Rash—Hydrocortisone—ulcerative colitis	4.93e-05	0.000231	CcSEcCtD
Sirolimus—Dermatitis—Hydrocortisone—ulcerative colitis	4.93e-05	0.000231	CcSEcCtD
Sirolimus—Headache—Hydrocortisone—ulcerative colitis	4.9e-05	0.00023	CcSEcCtD
Sirolimus—Dizziness—Triamcinolone—ulcerative colitis	4.87e-05	0.000228	CcSEcCtD
Sirolimus—Dizziness—Methylprednisolone—ulcerative colitis	4.86e-05	0.000228	CcSEcCtD
Sirolimus—Feeling abnormal—Prednisone—ulcerative colitis	4.79e-05	0.000225	CcSEcCtD
Sirolimus—Asthenia—Dexamethasone—ulcerative colitis	4.79e-05	0.000225	CcSEcCtD
Sirolimus—Asthenia—Betamethasone—ulcerative colitis	4.79e-05	0.000225	CcSEcCtD
Sirolimus—Gastrointestinal pain—Prednisone—ulcerative colitis	4.76e-05	0.000223	CcSEcCtD
Sirolimus—Nausea—Prednisolone—ulcerative colitis	4.76e-05	0.000223	CcSEcCtD
Sirolimus—Pruritus—Dexamethasone—ulcerative colitis	4.73e-05	0.000222	CcSEcCtD
Sirolimus—Pruritus—Betamethasone—ulcerative colitis	4.73e-05	0.000222	CcSEcCtD
Sirolimus—Vomiting—Triamcinolone—ulcerative colitis	4.68e-05	0.000219	CcSEcCtD
Sirolimus—Vomiting—Methylprednisolone—ulcerative colitis	4.67e-05	0.000219	CcSEcCtD
Sirolimus—Nausea—Hydrocortisone—ulcerative colitis	4.64e-05	0.000218	CcSEcCtD
Sirolimus—Rash—Triamcinolone—ulcerative colitis	4.64e-05	0.000218	CcSEcCtD
Sirolimus—Dermatitis—Triamcinolone—ulcerative colitis	4.64e-05	0.000217	CcSEcCtD
Sirolimus—Rash—Methylprednisolone—ulcerative colitis	4.63e-05	0.000217	CcSEcCtD
Sirolimus—Dermatitis—Methylprednisolone—ulcerative colitis	4.63e-05	0.000217	CcSEcCtD
Sirolimus—Headache—Triamcinolone—ulcerative colitis	4.61e-05	0.000216	CcSEcCtD
Sirolimus—Headache—Methylprednisolone—ulcerative colitis	4.6e-05	0.000216	CcSEcCtD
Sirolimus—Body temperature increased—Prednisone—ulcerative colitis	4.6e-05	0.000216	CcSEcCtD
Sirolimus—Abdominal pain—Prednisone—ulcerative colitis	4.6e-05	0.000216	CcSEcCtD
Sirolimus—Diarrhoea—Dexamethasone—ulcerative colitis	4.57e-05	0.000214	CcSEcCtD
Sirolimus—Diarrhoea—Betamethasone—ulcerative colitis	4.57e-05	0.000214	CcSEcCtD
Sirolimus—Dizziness—Dexamethasone—ulcerative colitis	4.42e-05	0.000207	CcSEcCtD
Sirolimus—Dizziness—Betamethasone—ulcerative colitis	4.42e-05	0.000207	CcSEcCtD
Sirolimus—Nausea—Triamcinolone—ulcerative colitis	4.37e-05	0.000205	CcSEcCtD
Sirolimus—Nausea—Methylprednisolone—ulcerative colitis	4.36e-05	0.000205	CcSEcCtD
Sirolimus—Hypersensitivity—Prednisone—ulcerative colitis	4.29e-05	0.000201	CcSEcCtD
Sirolimus—Vomiting—Betamethasone—ulcerative colitis	4.25e-05	0.000199	CcSEcCtD
Sirolimus—Vomiting—Dexamethasone—ulcerative colitis	4.25e-05	0.000199	CcSEcCtD
Sirolimus—Rash—Dexamethasone—ulcerative colitis	4.21e-05	0.000197	CcSEcCtD
Sirolimus—Rash—Betamethasone—ulcerative colitis	4.21e-05	0.000197	CcSEcCtD
Sirolimus—Dermatitis—Dexamethasone—ulcerative colitis	4.21e-05	0.000197	CcSEcCtD
Sirolimus—Dermatitis—Betamethasone—ulcerative colitis	4.21e-05	0.000197	CcSEcCtD
Sirolimus—Headache—Betamethasone—ulcerative colitis	4.19e-05	0.000196	CcSEcCtD
Sirolimus—Headache—Dexamethasone—ulcerative colitis	4.19e-05	0.000196	CcSEcCtD
Sirolimus—Asthenia—Prednisone—ulcerative colitis	4.17e-05	0.000196	CcSEcCtD
Sirolimus—Pruritus—Prednisone—ulcerative colitis	4.12e-05	0.000193	CcSEcCtD
Sirolimus—Diarrhoea—Prednisone—ulcerative colitis	3.98e-05	0.000187	CcSEcCtD
Sirolimus—Nausea—Dexamethasone—ulcerative colitis	3.97e-05	0.000186	CcSEcCtD
Sirolimus—Nausea—Betamethasone—ulcerative colitis	3.97e-05	0.000186	CcSEcCtD
Sirolimus—Dizziness—Prednisone—ulcerative colitis	3.85e-05	0.00018	CcSEcCtD
Sirolimus—Vomiting—Prednisone—ulcerative colitis	3.7e-05	0.000173	CcSEcCtD
Sirolimus—Rash—Prednisone—ulcerative colitis	3.67e-05	0.000172	CcSEcCtD
Sirolimus—Dermatitis—Prednisone—ulcerative colitis	3.66e-05	0.000172	CcSEcCtD
Sirolimus—Headache—Prednisone—ulcerative colitis	3.64e-05	0.000171	CcSEcCtD
Sirolimus—MTOR—Immune System—FCGR2A—ulcerative colitis	3.58e-05	0.000317	CbGpPWpGaD
Sirolimus—FGF2—Immune System—NOD2—ulcerative colitis	3.52e-05	0.000312	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CD14—ulcerative colitis	3.5e-05	0.00031	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—ADCY5—ulcerative colitis	3.49e-05	0.000309	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—GHRL—ulcerative colitis	3.48e-05	0.000308	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CXCR2—ulcerative colitis	3.48e-05	0.000308	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—NFKB1—ulcerative colitis	3.47e-05	0.000307	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—JAK2—ulcerative colitis	3.47e-05	0.000307	CbGpPWpGaD
Sirolimus—Nausea—Prednisone—ulcerative colitis	3.46e-05	0.000162	CcSEcCtD
Sirolimus—MTOR—Downstream signaling of activated FGFR—IL6—ulcerative colitis	3.44e-05	0.000305	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CHP1—ulcerative colitis	3.44e-05	0.000304	CbGpPWpGaD
Sirolimus—MTOR—Immune System—PTPN2—ulcerative colitis	3.43e-05	0.000304	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB4—IL6—ulcerative colitis	3.39e-05	0.0003	CbGpPWpGaD
Sirolimus—FGF2—Immune System—VCAM1—ulcerative colitis	3.38e-05	0.000299	CbGpPWpGaD
Sirolimus—FGF2—Immune System—HLA-DQA1—ulcerative colitis	3.37e-05	0.000298	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CALM3—ulcerative colitis	3.37e-05	0.000298	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—RELA—ulcerative colitis	3.36e-05	0.000297	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CDH1—ulcerative colitis	3.36e-05	0.000297	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—ADCY5—ulcerative colitis	3.33e-05	0.000295	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—RIPK2—ulcerative colitis	3.32e-05	0.000293	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCR1—ulcerative colitis	3.3e-05	0.000292	CbGpPWpGaD
Sirolimus—MTOR—Disease—MAML2—ulcerative colitis	3.28e-05	0.00029	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	3.27e-05	0.000289	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCR6—ulcerative colitis	3.27e-05	0.000289	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—NFKB1—ulcerative colitis	3.26e-05	0.000288	CbGpPWpGaD
Sirolimus—MTOR—Downstream signal transduction—IL6—ulcerative colitis	3.24e-05	0.000286	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	3.23e-05	0.000286	CbGpPWpGaD
Sirolimus—MTOR—Signaling by FGFR—IL6—ulcerative colitis	3.22e-05	0.000285	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—JAK2—ulcerative colitis	3.21e-05	0.000284	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB2—IL6—ulcerative colitis	3.21e-05	0.000284	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CRP—ulcerative colitis	3.19e-05	0.000282	CbGpPWpGaD
Sirolimus—MTOR—DAP12 signaling—IL6—ulcerative colitis	3.19e-05	0.000282	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IFNG—ulcerative colitis	3.15e-05	0.000279	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—STAT3—ulcerative colitis	3.12e-05	0.000276	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—RELA—ulcerative colitis	3.11e-05	0.000275	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MAML2—ulcerative colitis	3.1e-05	0.000274	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—JAK2—ulcerative colitis	3.07e-05	0.000271	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—TLR4—ulcerative colitis	3.06e-05	0.000271	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—TNF—ulcerative colitis	3.05e-05	0.00027	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CD4—ulcerative colitis	3.04e-05	0.000269	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	3.02e-05	0.000267	CbGpPWpGaD
Sirolimus—MTOR—Signaling by FGFR in disease—IL6—ulcerative colitis	3e-05	0.000265	CbGpPWpGaD
Sirolimus—MTOR—DAP12 interactions—IL6—ulcerative colitis	3e-05	0.000265	CbGpPWpGaD
Sirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—ulcerative colitis	3e-05	0.000265	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR—IL6—ulcerative colitis	2.97e-05	0.000263	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—DLD—ulcerative colitis	2.97e-05	0.000263	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—RELA—ulcerative colitis	2.97e-05	0.000263	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR in Cancer—IL6—ulcerative colitis	2.95e-05	0.000261	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—HLA-DRB1—ulcerative colitis	2.94e-05	0.00026	CbGpPWpGaD
Sirolimus—MTOR—Signaling by PDGF—IL6—ulcerative colitis	2.94e-05	0.00026	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CALM3—ulcerative colitis	2.93e-05	0.000259	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—STAT3—ulcerative colitis	2.93e-05	0.000259	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CD4—ulcerative colitis	2.91e-05	0.000257	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCL20—ulcerative colitis	2.89e-05	0.000256	CbGpPWpGaD
Sirolimus—MTOR—Immune System—RIPK2—ulcerative colitis	2.89e-05	0.000255	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—ADRB2—ulcerative colitis	2.88e-05	0.000255	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—PTGER4—ulcerative colitis	2.88e-05	0.000255	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—MMP9—ulcerative colitis	2.86e-05	0.000253	CbGpPWpGaD
Sirolimus—FGF2—Immune System—ADCY5—ulcerative colitis	2.86e-05	0.000253	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—RELA—ulcerative colitis	2.85e-05	0.000252	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CTLA4—ulcerative colitis	2.84e-05	0.000252	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—NFKB1—ulcerative colitis	2.83e-05	0.000251	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—ICAM1—ulcerative colitis	2.82e-05	0.000249	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.81e-05	0.000249	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL1B—ulcerative colitis	2.81e-05	0.000249	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL2—ulcerative colitis	2.8e-05	0.000248	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CD4—ulcerative colitis	2.79e-05	0.000247	CbGpPWpGaD
Sirolimus—FGF2—Signaling by NGF—IL6—ulcerative colitis	2.76e-05	0.000244	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—GNA12—ulcerative colitis	2.72e-05	0.000241	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD79A—ulcerative colitis	2.71e-05	0.00024	CbGpPWpGaD
Sirolimus—MTOR—Disease—CALM3—ulcerative colitis	2.7e-05	0.000239	CbGpPWpGaD
Sirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	2.66e-05	0.000235	CbGpPWpGaD
Sirolimus—FGF2—Disease—ADCY5—ulcerative colitis	2.64e-05	0.000234	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—GHRL—ulcerative colitis	2.63e-05	0.000233	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—NFKB1—ulcerative colitis	2.62e-05	0.000232	CbGpPWpGaD
Sirolimus—MTOR—Immune System—NOD2—ulcerative colitis	2.62e-05	0.000231	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD14—ulcerative colitis	2.6e-05	0.00023	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CHP1—ulcerative colitis	2.6e-05	0.00023	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCR2—ulcerative colitis	2.58e-05	0.000228	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CALM3—ulcerative colitis	2.55e-05	0.000226	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—STAT3—ulcerative colitis	2.55e-05	0.000225	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—RIPK2—ulcerative colitis	2.51e-05	0.000222	CbGpPWpGaD
Sirolimus—MTOR—Immune System—VCAM1—ulcerative colitis	2.51e-05	0.000222	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CRP—ulcerative colitis	2.51e-05	0.000222	CbGpPWpGaD
Sirolimus—MTOR—Immune System—HLA-DQA1—ulcerative colitis	2.5e-05	0.000221	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—NFKB1—ulcerative colitis	2.5e-05	0.000221	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CDH1—ulcerative colitis	2.49e-05	0.00022	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—ADCY5—ulcerative colitis	2.44e-05	0.000216	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCR6—ulcerative colitis	2.43e-05	0.000215	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—NFKB1—ulcerative colitis	2.4e-05	0.000213	CbGpPWpGaD
Sirolimus—FGF2—Immune System—TLR4—ulcerative colitis	2.4e-05	0.000212	CbGpPWpGaD
Sirolimus—FGF2—Immune System—HLA-DRB1—ulcerative colitis	2.4e-05	0.000212	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—TP53—ulcerative colitis	2.38e-05	0.000211	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.37e-05	0.000209	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—TGFB1—ulcerative colitis	2.36e-05	0.000209	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—STAT3—ulcerative colitis	2.36e-05	0.000208	CbGpPWpGaD
Sirolimus—FGF2—Immune System—ICAM1—ulcerative colitis	2.3e-05	0.000204	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MAML2—ulcerative colitis	2.3e-05	0.000203	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—JAK2—ulcerative colitis	2.27e-05	0.000201	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—DLD—ulcerative colitis	2.24e-05	0.000198	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.23e-05	0.000197	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—TNF—ulcerative colitis	2.2e-05	0.000195	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—RELA—ulcerative colitis	2.2e-05	0.000195	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—ADRB2—ulcerative colitis	2.18e-05	0.000193	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—IL6—ulcerative colitis	2.18e-05	0.000193	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—JAK2—ulcerative colitis	2.17e-05	0.000192	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PTGS1—ulcerative colitis	2.16e-05	0.000191	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CD4—ulcerative colitis	2.16e-05	0.000191	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PTGER4—ulcerative colitis	2.14e-05	0.000189	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.13e-05	0.000188	CbGpPWpGaD
Sirolimus—MTOR—Immune System—ADCY5—ulcerative colitis	2.13e-05	0.000188	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—RELA—ulcerative colitis	2.12e-05	0.000187	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—JAK2—ulcerative colitis	2.08e-05	0.000184	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CD4—ulcerative colitis	2.07e-05	0.000183	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—CD4—ulcerative colitis	2.06e-05	0.000182	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—PTGS2—ulcerative colitis	2.05e-05	0.000181	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—IL6—ulcerative colitis	2.04e-05	0.000181	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CDH1—ulcerative colitis	2.04e-05	0.00018	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.02e-05	0.000179	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—RELA—ulcerative colitis	2.01e-05	0.000178	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PTGS1—ulcerative colitis	1.99e-05	0.000176	CbGpPWpGaD
Sirolimus—MTOR—Disease—ADCY5—ulcerative colitis	1.96e-05	0.000174	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—GHRL—ulcerative colitis	1.96e-05	0.000173	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CALM3—ulcerative colitis	1.95e-05	0.000172	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.94e-05	0.000171	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CXCL8—ulcerative colitis	1.9e-05	0.000168	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CALM3—ulcerative colitis	1.89e-05	0.000167	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—RIPK2—ulcerative colitis	1.87e-05	0.000165	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.86e-05	0.000165	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CRP—ulcerative colitis	1.86e-05	0.000164	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—NFKB1—ulcerative colitis	1.86e-05	0.000164	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—ADCY5—ulcerative colitis	1.85e-05	0.000164	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IL2—ulcerative colitis	1.81e-05	0.00016	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CALM3—ulcerative colitis	1.79e-05	0.000158	CbGpPWpGaD
Sirolimus—FGF2—Immune System—JAK2—ulcerative colitis	1.79e-05	0.000158	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—NFKB1—ulcerative colitis	1.78e-05	0.000158	CbGpPWpGaD
Sirolimus—MTOR—Immune System—TLR4—ulcerative colitis	1.78e-05	0.000158	CbGpPWpGaD
Sirolimus—MTOR—Immune System—HLA-DRB1—ulcerative colitis	1.78e-05	0.000157	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—IL6—ulcerative colitis	1.78e-05	0.000157	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IFNG—ulcerative colitis	1.75e-05	0.000155	CbGpPWpGaD
Sirolimus—FGF2—Immune System—RELA—ulcerative colitis	1.73e-05	0.000153	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—MMP9—ulcerative colitis	1.71e-05	0.000152	CbGpPWpGaD
Sirolimus—MTOR—Immune System—ICAM1—ulcerative colitis	1.71e-05	0.000151	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—NFKB1—ulcerative colitis	1.7e-05	0.00015	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CD4—ulcerative colitis	1.69e-05	0.00015	CbGpPWpGaD
Sirolimus—FGF2—Disease—JAK2—ulcerative colitis	1.65e-05	0.000146	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL6—ulcerative colitis	1.65e-05	0.000146	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—ADRB2—ulcerative colitis	1.62e-05	0.000143	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.61e-05	0.000143	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.6e-05	0.000141	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—STAT3—ulcerative colitis	1.6e-05	0.000141	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—IL6—ulcerative colitis	1.57e-05	0.000139	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL1B—ulcerative colitis	1.56e-05	0.000138	CbGpPWpGaD
Sirolimus—FGF2—Disease—CD4—ulcerative colitis	1.56e-05	0.000138	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL2—ulcerative colitis	1.56e-05	0.000138	CbGpPWpGaD
Sirolimus—FGF2—Disease—PTGS2—ulcerative colitis	1.55e-05	0.000137	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—STAT3—ulcerative colitis	1.52e-05	0.000135	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—JAK2—ulcerative colitis	1.52e-05	0.000135	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ABCB1—ulcerative colitis	1.51e-05	0.000134	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CDH1—ulcerative colitis	1.51e-05	0.000134	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.51e-05	0.000134	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.51e-05	0.000133	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—TGFB1—ulcerative colitis	1.48e-05	0.000131	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—RELA—ulcerative colitis	1.47e-05	0.00013	CbGpPWpGaD
Sirolimus—FGF2—Immune System—NFKB1—ulcerative colitis	1.46e-05	0.000129	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PTGS1—ulcerative colitis	1.44e-05	0.000127	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ADCY5—ulcerative colitis	1.41e-05	0.000125	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TGFB1—ulcerative colitis	1.41e-05	0.000125	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ABCB1—ulcerative colitis	1.39e-05	0.000123	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CXCL8—ulcerative colitis	1.39e-05	0.000123	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—DLD—ulcerative colitis	1.38e-05	0.000122	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—ADCY5—ulcerative colitis	1.37e-05	0.000122	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL2—ulcerative colitis	1.33e-05	0.000117	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.33e-05	0.000117	CbGpPWpGaD
Sirolimus—MTOR—Immune System—JAK2—ulcerative colitis	1.32e-05	0.000117	CbGpPWpGaD
Sirolimus—FGF2—Immune System—STAT3—ulcerative colitis	1.31e-05	0.000116	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IFNG—ulcerative colitis	1.3e-05	0.000115	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ADCY5—ulcerative colitis	1.3e-05	0.000115	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CALM3—ulcerative colitis	1.29e-05	0.000114	CbGpPWpGaD
Sirolimus—MTOR—Immune System—RELA—ulcerative colitis	1.28e-05	0.000113	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MMP9—ulcerative colitis	1.26e-05	0.000111	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD4—ulcerative colitis	1.26e-05	0.000111	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NFKB1—ulcerative colitis	1.24e-05	0.00011	CbGpPWpGaD
Sirolimus—MTOR—Disease—JAK2—ulcerative colitis	1.22e-05	0.000108	CbGpPWpGaD
Sirolimus—FGF2—Disease—STAT3—ulcerative colitis	1.21e-05	0.000107	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—IL6—ulcerative colitis	1.17e-05	0.000103	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TP53—ulcerative colitis	1.16e-05	0.000103	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL1B—ulcerative colitis	1.16e-05	0.000103	CbGpPWpGaD
Sirolimus—MTOR—Disease—CD4—ulcerative colitis	1.16e-05	0.000103	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL2—ulcerative colitis	1.16e-05	0.000102	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—JAK2—ulcerative colitis	1.15e-05	0.000102	CbGpPWpGaD
Sirolimus—MTOR—Disease—PTGS2—ulcerative colitis	1.15e-05	0.000102	CbGpPWpGaD
Sirolimus—FGF2—Disease—TGFB1—ulcerative colitis	1.12e-05	9.92e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—STAT3—ulcerative colitis	1.12e-05	9.89e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—RELA—ulcerative colitis	1.12e-05	9.89e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—IL6—ulcerative colitis	1.11e-05	9.86e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.08e-05	9.58e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—NFKB1—ulcerative colitis	1.08e-05	9.57e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IL6—ulcerative colitis	1.06e-05	9.41e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PPARG—ulcerative colitis	1.05e-05	9.32e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CXCL8—ulcerative colitis	1.05e-05	9.32e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TGFB1—ulcerative colitis	1.04e-05	9.16e-05	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.01e-05	8.96e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL2—ulcerative colitis	1.01e-05	8.9e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ABCB1—ulcerative colitis	1e-05	8.89e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CALM3—ulcerative colitis	9.75e-06	8.62e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—STAT3—ulcerative colitis	9.72e-06	8.6e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PPARG—ulcerative colitis	9.67e-06	8.55e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MMP9—ulcerative colitis	9.53e-06	8.43e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ALB—ulcerative colitis	9.48e-06	8.38e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NFKB1—ulcerative colitis	9.43e-06	8.34e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ADCY5—ulcerative colitis	9.37e-06	8.29e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL6—ulcerative colitis	9.15e-06	8.09e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—STAT3—ulcerative colitis	8.98e-06	7.94e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ALB—ulcerative colitis	8.7e-06	7.69e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—JAK2—ulcerative colitis	8.57e-06	7.58e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TP53—ulcerative colitis	8.53e-06	7.54e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—STAT3—ulcerative colitis	8.47e-06	7.49e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—IL6—ulcerative colitis	8.45e-06	7.47e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—TGFB1—ulcerative colitis	8.32e-06	7.36e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—RELA—ulcerative colitis	8.3e-06	7.34e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PTGS2—ulcerative colitis	8.29e-06	7.33e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TGFB1—ulcerative colitis	7.85e-06	6.95e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCL8—ulcerative colitis	7.82e-06	6.91e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL6—ulcerative colitis	7.81e-06	6.91e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PTGS2—ulcerative colitis	7.61e-06	6.73e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL2—ulcerative colitis	7.47e-06	6.61e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ADCY5—ulcerative colitis	7.07e-06	6.26e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MMP9—ulcerative colitis	7.07e-06	6.25e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NFKB1—ulcerative colitis	7e-06	6.19e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PPARG—ulcerative colitis	6.99e-06	6.18e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL6—ulcerative colitis	6.79e-06	6.01e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGS1—ulcerative colitis	6.67e-06	5.9e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TP53—ulcerative colitis	6.46e-06	5.72e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—STAT3—ulcerative colitis	6.29e-06	5.56e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ALB—ulcerative colitis	6.29e-06	5.56e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—IL6—ulcerative colitis	6.27e-06	5.55e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CALM3—ulcerative colitis	6.01e-06	5.31e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL6—ulcerative colitis	5.92e-06	5.23e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TGFB1—ulcerative colitis	5.83e-06	5.15e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PTGS2—ulcerative colitis	5.5e-06	4.86e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PPARG—ulcerative colitis	5.28e-06	4.67e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TP53—ulcerative colitis	4.8e-06	4.24e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ALB—ulcerative colitis	4.74e-06	4.2e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ABCB1—ulcerative colitis	4.67e-06	4.13e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL6—ulcerative colitis	4.39e-06	3.88e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ADCY5—ulcerative colitis	4.36e-06	3.85e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGS2—ulcerative colitis	4.15e-06	3.67e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PPARG—ulcerative colitis	3.25e-06	2.87e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ALB—ulcerative colitis	2.92e-06	2.58e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.56e-06	2.26e-05	CbGpPWpGaD
